Skip to main content
. Author manuscript; available in PMC: 2024 Mar 1.
Published in final edited form as: Nutrition. 2022 Dec 10;107:111934. doi: 10.1016/j.nut.2022.111934

Table 1.

Summary of study characteristics

Cancer survivors (N=946)
Matched cohort (N=1,857)
Overall
N (col%)
No LMM
N (row%)
With LMM
N (row%)
Overall
N (col%)
No LMM
N (row%)
With LMM
N (row%)
Age (year)
<50 227 (24.0) 199 (87.7) 28 (12.3) 454 (24.5) 404 (89.0) 50 (11.0)
50-64 312 (33.0) 254 (81.4) 58 (18.6) 624 (33.6) 531 (85.1) 93 (14.9)
65-74 209 (22.1) 166 (79.4) 43 (20.6) 411 (22.1) 319 (77.6) 92 (22.4)
≥75 198 (20.9) 117 (59.1) 81 (40.9) 368 (19.8) 238 (64.7) 130 (35.3)
Sex
Female 540 (57.1) 433 (80.2) 107 (19.8) 1062 (57.2) 892 (84.0) 170 (16.0)
Male 406 (42.9) 303 (74.6) 103 (25.4) 795 (42.8) 600 (75.5) 195 (24.5)
Race
White 685 (72.4) 515 (75.2) 170 (24.8) 1337 (72.0) 1043 (78.0) 294 (22.0)
Black 122 (12.9) 108 (88.5) 14 (11.5) 242 (13.0) 223 (92.2) 19 (7.9)
Other 139 (14.7) 113 (81.3) 26 (18.7) 278 (15.0) 226 (81.3) 52 (18.7)
Education
High school or less 437 (46.2) 334 (76.4) 103 (23.6) 958 (51.6) 757 (79.0) 201 (21.0)
Attended college 263 (27.8) 205 (78.0) 58 (22.1) 468 (25.2) 386 (82.5) 82 (17.5)
Graduated from college 246 (26.0) 197 (80.1) 49 (19.9) 431 (23.2) 349 (81.0) 82 (19.0)
Marital status
Not married 326 (34.5) 252 (77.3) 74 (22.7) 647 (34.8) 503 (77.7) 144 (22.3)
Married or living with partner 620 (65.5) 484 (78.1) 136 (21.9) 1210 (65.2) 989 (81.7) 221 (18.3)
Smoking status
Never 404 (42.7) 327 (80.9) 77 (19.1) 923 (49.7) 770 (83.4) 153 (16.6)
Current 190 (20.1) 144 (75.8) 46 (24.2) 330 (17.8) 245 (74.2) 85 (25.8)
Former 352 (37.2) 265 (75.3) 87 (24.7) 604 (32.5) 477 (79.0) 127 (21.0)
RFM *
Low 145 (15.3) 69 (47.6) 76 (52.4) 275 (14.8) 135 (49.1) 140 (50.9)
Moderate 289 (30.6) 204 (70.6) 85 (29.4) 560 (30.2) 416 (74.3) 144 (25.7)
High 512 (54.1) 463 (90.4) 49 (9.6) 1,022 (55.0) 941 (92.1) 81 (7.9)
Energy intake (kcal/day)
<1,364.0 236 (25.0) 169 (71.6) 67 (28.4) 488 (26.3) 389 (79.7) 99 (20.3)
1,364.0-1,790.2 237 (25.0) 176 (74.3) 61 (25.7) 465 (25.0) 374 (80.4) 91 (19.6)
1,790.3-2,339.9 236 (25.0) 190 (80.5) 46 (19.5) 501 (27.0) 393 (78.4) 108 (21.6)
≥2,340.0 237 (25.0) 201 (84.8) 36 (15.2) 403 (21.7) 336 (83.4) 67 (16.6)
Regular exercise
No 403 (42.6) 302 (74.9) 101 (25.1) 812 (43.7) 640 (78.8) 172 (21.2)
Yes 543 (57.4) 434 (79.9) 109 (20.1) 1,045 (56.3) 852 (81.5) 193 (18.5)
No. comorbidities
0 417 (44.1) 317 (76.0) 100 (24.0) 963 (51.9) 765 (79.4) 198 (20.6)
1 318 (33.6) 257 (80.8) 61 (19.2) 580 (31.2) 478 (82.4) 102 (17.6)
≥2 211 (22.3) 162 (76.8) 49 (23.2) 314 (16.9) 249 (79.3) 65 (20.7)
Chronic kidney disease
No 911 (96.3) 710 (77.9) 201 (22.1) 1804 (97.2) 1454 (80.6) 350 (19.4)
Yes 35 (3.7) 26 (74.3) 9 (25.7) 53 (2.9) 38 (71.7) 15 (28.3)
Hypertension
No 507 (53.6) 386 (76.1) 121 (23.9) 1114 (60.0) 877 (78.7) 237 (21.3)
Yes 439 (46.4) 350 (79.7) 89 (20.3) 743 (40.0) 615 (82.8) 128 (17.2)
Diabetes mellitus
No 795 (84.0) 611 (76.9) 184 (23.1) 1639 (88.3) 1311 (80.0) 328 (20.0)
Yes 151 (16.0) 125 (82.8) 26 (17.2) 218 (11.7) 181 (83.0) 37 (17.0)
Heart attack
No 877 (92.7) 685 (78.1) 192 (21.9) 1759 (94.7) 1419 (80.7) 340 (19.3)
Yes 69 (7.3) 51 (73.9) 18 (26.1) 98 (5.3) 73 (74.5) 25 (25.5)
Stroke
No 891 (94.2) 698 (78.3) 193 (21.7) 1774 (95.5) 1429 (80.6) 345 (19.5)
Yes 55 (5.8) 38 (69.1) 17 (30.9) 83 (4.5) 63 (75.9) 20 (24.1)
Coronary heart disease
No 871 (92.1) 681 (78.2) 190 (21.8) 1745 (94.0) 1404 (80.5) 341 (19.5)
Yes 75 (7.9) 55 (73.3) 20 (26.7) 112 (6.0) 88 (78.6) 24 (21.4)
Congestive heart failure
No 900 (95.1) 701 (77.9) 199 (22.1) 1795 (96.7) 1446 (80.6) 349 (19.4)
Yes 46 (4.9) 35 (76.1) 11 (23.9) 62 (3.3) 46 (74.2) 16 (25.8)
History of more than 1 cancer
No 860 (90.9) 676 (78.6) 184 (21.4) N/A N/A N/A
Yes 86 (9.1) 60 (69.8) 26 (30.2) N/A N/A N/A
Time elapsed since cancer diagnosis (year)
1-4 310 (32.8) 245 (79.0) 65 (21.0) N/A N/A N/A
5-9 234 (24.7) 184 (78.6) 50 (21.4) N/A N/A N/A
≥10 402 (42.5) 307 (76.4) 95 (23.6) N/A N/A N/A
Cancer type
Breast 134 (14.2) 103 (76.9) 31 (23.1) N/A N/A N/A
Prostate 119 (12.6) 84 (70.6) 35 (29.4) N/A N/A N/A
Colorectal 55 (5.8) 42 (76.4) 13 (23.6) N/A N/A N/A
Melanoma 57 (6.0) 47 (82.5) 10 (17.5) N/A N/A N/A
Other 581 (61.4) 460 (79.2) 121 (20.8) N/A N/A N/A

Abbreviation: RFM: relative fat mass

*

Cutoffs of relative fat mass were as follows—low: female: <35%, male: <25%; moderate: female: 35–39.9%, male: 25–29.9%; high: female: ≥40%, male: ≥30%.